Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Financings
Financings
| Raise | Date |
|---|---|
| Public offering of common stock and pre-funded warrants Update: about US$130M · US$16 a share · Guggenheim Securities +5 Dealers: Guggenheim Securities (co-lead), Cantor (co-lead), Raymond James, Needham & Company, H.C. Wainwright & Co., Craig-Hallum Use of proceeds: General corporate purposes, including working capital and commercialization and research and development expenses | Jan 8, 2026 |